دورية أكاديمية
Identification of small-molecule protein-protein interaction inhibitors for NKG2D.
| العنوان: | Identification of small-molecule protein-protein interaction inhibitors for NKG2D. |
|---|---|
| المؤلفون: | Thompson AA; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Harbut MB; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Kung PP; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Karpowich NK; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Branson JD; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Grant JC; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Hagan D; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Pascual HA; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Bai G; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Zavareh RB; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Coate HR; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Collins BC; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Côte M; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Gelin CF; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Damm-Ganamet KL; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Gholami H; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Huff AR; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Limon L; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Lumb KJ; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Mak PA; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Nakafuku KM; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Price EV; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Shih AY; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Tootoonchi M; Discovery Immunology, Janssen Research & Development, San Diego, CA 92121., Vellore NA; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Wang J; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Wei N; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Ziff J; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Berger SB; Discovery Immunology, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Edwards JP; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Gardet A; Discovery Immunology, Janssen Research & Development, San Diego, CA 92121., Sun S; Discovery Immunology, Janssen Research & Development, San Diego, CA 92121., Towne JE; Discovery Immunology, Janssen Research & Development, San Diego, CA 92121., Venable JD; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Shi Z; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Venkatesan H; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Rives ML; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Sharma S; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002., Shireman BT; Therapeutics Discovery, Janssen Research & Development, San Diego, CA 92121., Allen SJ; Therapeutics Discovery, Janssen Research & Development, Lower Gwynedd Township, PA 19002. |
| المصدر: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 May 02; Vol. 120 (18), pp. e2216342120. Date of Electronic Publication: 2023 Apr 25. |
| نوع المنشور: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S. |
| اللغة: | English |
| بيانات الدورية: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Washington, DC : National Academy of Sciences |
| مواضيع طبية MeSH: | Killer Cells, Natural* , NK Cell Lectin-Like Receptor Subfamily K*, Ligands ; CD8-Positive T-Lymphocytes ; Protein Binding |
| مستخلص: | NKG2D (natural-killer group 2, member D) is a homodimeric transmembrane receptor that plays an important role in NK, γδ + , and CD8 + T cell-mediated immune responses to environmental stressors such as viral or bacterial infections and oxidative stress. However, aberrant NKG2D signaling has also been associated with chronic inflammatory and autoimmune diseases, and as such NKG2D is thought to be an attractive target for immune intervention. Here, we describe a comprehensive small-molecule hit identification strategy and two distinct series of protein-protein interaction inhibitors of NKG2D. Although the hits are chemically distinct, they share a unique allosteric mechanism of disrupting ligand binding by accessing a cryptic pocket and causing the two monomers of the NKG2D dimer to open apart and twist relative to one another. Leveraging a suite of biochemical and cell-based assays coupled with structure-based drug design, we established tractable structure-activity relationships with one of the chemical series and successfully improved both the potency and physicochemical properties. Together, we demonstrate that it is possible, albeit challenging, to disrupt the interaction between NKG2D and multiple protein ligands with a single molecule through allosteric modulation of the NKG2D receptor dimer/ligand interface. |
| References: | Front Immunol. 2018 May 30;9:1219. (PMID: 29910814) Science. 1999 Jul 30;285(5428):730-2. (PMID: 10426994) J Med Chem. 2010 Jul 22;53(14):5061-84. (PMID: 20345171) Acta Crystallogr D Biol Crystallogr. 2006 Jul;62(Pt 7):741-9. (PMID: 16790930) Structure. 2003 Apr;11(4):411-22. (PMID: 12679019) Immunity. 2001 Dec;15(6):1039-49. (PMID: 11754823) Immunity. 2002 Mar;16(3):345-54. (PMID: 11911820) Science. 1998 Feb 20;279(5354):1166-72. (PMID: 9469799) Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. (PMID: 20383002) Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1603-8. (PMID: 12582206) Mol Immunol. 2002 May;38(14):1029-37. (PMID: 11955595) Adv Appl Bioinform Chem. 2020 Nov 12;13:11-25. (PMID: 33209039) Chemistry. 2009;15(3):585-8. (PMID: 19065697) J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. (PMID: 19461840) Cancer Immunol Res. 2015 Jun;3(6):575-82. (PMID: 26041808) Nat Commun. 2019 Dec 19;10(1):5795. (PMID: 31857588) Science. 2005 Nov 11;310(5750):1022-5. (PMID: 16284179) Proc Natl Acad Sci U S A. 2005 May 24;102(21):7641-6. (PMID: 15894612) Sci Signal. 2017 May 30;10(481):. (PMID: 28559451) Bioorg Med Chem Lett. 2009 Aug 1;19(15):4406-9. (PMID: 19500981) Structure. 2000 Jul 15;8(7):R137-42. (PMID: 10903952) J Chem Inf Model. 2017 Aug 28;57(8):1881-1894. (PMID: 28727915) Science. 1992 Feb 21;255(5047):959-65. (PMID: 1546293) Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. (PMID: 20124702) J Immunol. 2002 Dec 1;169(11):6279-85. (PMID: 12444134) Drug Discov Today. 2004 May 15;9(10):430-1. (PMID: 15109945) Adv Protein Chem Struct Biol. 2020;121:253-303. (PMID: 32312425) Sci Rep. 2016 Aug 16;6:30859. (PMID: 27527709) J Nat Prod. 2018 Jan 26;81(1):203-210. (PMID: 29323895) Sci Rep. 2016 May 17;6:26071. (PMID: 27184415) Nat Immunol. 2001 May;2(5):443-51. (PMID: 11323699) Acta Crystallogr D Struct Biol. 2018 Feb 1;74(Pt 2):85-97. (PMID: 29533234) Nat Rev Drug Discov. 2007 Nov;6(11):881-90. (PMID: 17971784) Annu Rev Biochem. 2018 Jun 20;87:479-502. (PMID: 29328784) Immunity. 2003 Dec;19(6):803-12. (PMID: 14670298) |
| فهرسة مساهمة: | Keywords: DNA-encoded library screening; NKG2D; inflammation; protein–protein interaction |
| المشرفين على المادة: | 0 (NK Cell Lectin-Like Receptor Subfamily K) 0 (Ligands) |
| تواريخ الأحداث: | Date Created: 20230425 Date Completed: 20230427 Latest Revision: 20231026 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10160951 |
| DOI: | 10.1073/pnas.2216342120 |
| PMID: | 37098070 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1091-6490 |
|---|---|
| DOI: | 10.1073/pnas.2216342120 |